EP1157270A1 - Multichannel control in microfluidics - Google Patents

Multichannel control in microfluidics

Info

Publication number
EP1157270A1
EP1157270A1 EP00905943A EP00905943A EP1157270A1 EP 1157270 A1 EP1157270 A1 EP 1157270A1 EP 00905943 A EP00905943 A EP 00905943A EP 00905943 A EP00905943 A EP 00905943A EP 1157270 A1 EP1157270 A1 EP 1157270A1
Authority
EP
European Patent Office
Prior art keywords
barrier
particles
channel
site
microfluidic device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00905943A
Other languages
German (de)
French (fr)
Inventor
Aran Paulus
Alexander Sassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monogram Biosciences Inc
Original Assignee
Aclara Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aclara Biosciences Inc filed Critical Aclara Biosciences Inc
Publication of EP1157270A1 publication Critical patent/EP1157270A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502738Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44743Introducing samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0647Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0668Trapping microscopic beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16Reagents, handling or storing thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/069Absorbents; Gels to retain a fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/087Multiple sequential chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0415Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0415Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
    • B01L2400/0421Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0633Valves, specific forms thereof with moving parts
    • B01L2400/065Valves, specific forms thereof with moving parts sliding valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0633Valves, specific forms thereof with moving parts
    • B01L2400/0661Valves, specific forms thereof with moving parts shape memory polymer valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0677Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers

Definitions

  • the field of this invention is microfluidics, using an electrical field to move particles through capillaries.
  • Microfluidics employs capillaries as the channel in which various activities occur, where electrical Fields or pressure differentials are created in the channels to move mixture components from site to site.
  • These new miniature systems have expanded on the electrophoretic capabilities in providing chemical laboratories on a chip, where one may have a plurality of intersecting channels, reagent chambers and the ability to change the environment at individual sites or for the entire device.
  • the present miniature devices are not limited to separation, but allow for chemical reaction, affinity binding, diagnostic assays, identification of entities, the manipulation of very small volumes for any purpose and other operations.
  • FIG. 5 is a diagrammatic view of a channel layout.
  • Microfluidic devices are provided where barriers to flow are introduced at intersections between functional areas of the device, which barriers are porous and allow for movement of chemical entities under the influence of an electrical field or may be removed.
  • the barriers may take a variety of forms: formed of a polymeric composition, which may be preformed or formed in situ magnetic beads.
  • the microfluidic devices have a plurality of functional areas comprising at least one capillary channel or trough and may have reagent chambers, where the cross-sectional dimensions of the chamber will be greater than the cross- sectional dimensions of the channel, which area may be referred to as the "movement area.”
  • the microfluidic devices arc used- to manipulate particles, which may be charged or uncharged, and include individual entities, such as ions and molecules, as well as aggregates of entities, such as complexes involving two or more molecules, large aggregates, such as organelles, cells, viruses, or other entities, usually less than about l ⁇ .
  • the microfluidic devices will usually be small solid substrates, which may be referred to as chips.
  • the substrate may be any convenient material, including plastics, e.g. acrylics, glass, silicon, ceramic, or other convenient material, which may be fabricated.
  • the devices may be long sheets or slabs comprising numerous fluidic systems. However, generally, the largest dimension will be less than about 100cm, usually less than about 50cm and not less than about 1cm. Depending on the particular function of the device, the device may range from about 10 to 20 cm or longer, for example for DNA sequencing, or from about 2 to 10 cm, for other applications, such as drug screening.
  • the thickness of the device may be varied and may involve a number of different layers, particularly where temperature control is provided.
  • the device will be at least about 10 ⁇ m high or thick and not more than about 50 mm, usually not more than about 20 mm.
  • the channels will usually have cross-sections in the range of about 25 to 2000 ⁇ m 2 , more usually in the range of about 100 to 500 ⁇ m , although in some instances the channels may be larger or smaller by an order of 10.
  • Channels may be of varying length, usually be at least about 5 ⁇ m and may run substantially the length of the device, usually being less than about 100 cm, more usually being less than about 50 cm, frequently less than about 15 cm, where the channel maybe interrupted by one or more chambers. Again, the length of the channel will generally be determined by the function for which the device is being used.
  • the channel may be straight, angled, tortuous, or any path, depending on the nature of the device and its use.
  • a cover will be used to enclose the channels and chambers, which cover may be a film, plate, or the like, and may provide ports for introduction and removal of fluids, provide for electrodes to contact the media in the channels and chambers, may also serve to control the environment as specific sites, e.g. temperature, provide access to light for introducing radiation and/or observing radiation, and the like.
  • the substrate may provide one or more of these features.
  • ports and electrodes may be along the edges of the device.
  • the device may have a single microfluidic system or a plurality of microfluidic systems, which may be run concurrently or independently.
  • the number of fluidic systems will be at least one and not more than about 5,000, usually not more than about 1,000.
  • the device will usually include one or more source and/or waste wells, which may provide tile fluid for the channel, particularly for separations, and accommodate the waste from one or more systems or a single system may have a plurality of source and waste wells, generally from about 1 to 10, usually from about 1 to 5 of each.
  • wells may be external to the device and feed and receive fluids through conduits connected to the ports.
  • the electrodes can be formed photolithographically to be in contact with the media at specific positions in the channels and, when appropriate, in the chambers and wells.
  • the electrodes may be individually positioned exterior to the device and extend into a capillary or chamber through a port or a combination of the two methods may be employed.
  • the device will usually be used with an automated instrument, which may provide the electrodes or contacts to the electrodes.
  • an automated instrument which may provide the electrodes or contacts to the electrodes.
  • the barriers may be of any length above a minimum of about 0.05 ⁇ m.
  • the barriers which will be employed will generally be at least about 0.1 mm, more usually at least about 0.2 mm, and may be much larger, usually not exceeding the length of a channel, usually not more than about 1 cm, more usually not exceeding 0.5 cm, and preferably not exceeding 0.25 cm, depending on the nature of the composition of the barrier, the function of the barrier, the manner of formation, and the like.
  • the composition will be a free-flowing composition comprised of a material, which may have one or more components, which will produce a physical barrier to fluid flow.
  • the composition may have a monomer, which by itself or in combination with other components, will polymerize, particularly under photoinitiation, or a composition which will gel or solidify by a change in conditions, e.g. temperature, pH, solvent, ionic strength, etc.
  • Various monomers may be employed, including monomers which find use in gel electrophoresis, such as acryl (including methacryl) monomers, particularly acrylamides, where the nitrogen may be substituted, thermo-reversible polymers, where heating or cooling results in a change in their physical properties, such as acrylic polymers, e.g. hydroxyalkylacrylamides and - methacrylamides, hydroxyalkylacrylates and -methacrylates, silicones, sulfonated styrenes, urethane oligomers, polysaccharides, e.g. agarose and hydroxyalkylcellulose, etc. See particularly, U.S. Patent nos. 5,569,364 and 5,672,297.
  • Polymeric particles may be employed where a change in the medium results in the swelling or shrinking of the particles.
  • acrylamides which are polymerized with a photoinitiator and the composition may include a cross-linker, which cross-linker is stable or labile, particularly labile, more particularly photolytically labile at a shorter wavelength than the wavelength used for photoinitiation.
  • the cross-linker may be thermally or chemically labile or the polymer may be soluble in a solvent which can be accommodated by the system.
  • barrier- forming composition examples include azo, disulfide, peroxide, -diketo, etc.
  • functional groups which may be employed include azo, disulfide, peroxide, -diketo, etc.
  • non-cross-linked and cross-linked polymers are envisioned.
  • the barriers may then be formed at the desired sites.
  • masks which may be photolithographic masks, ink designs on the surface of the device, focused light or other means for limiting the radiation to the site of interest, formation of the barrier will be restricted to the area being Irradiated. For example, if one wishes to protect side channels from leakage of the medium in a main channel, formation of the barrier is performed at the sites of intersection of the main channel.
  • control of the site of the barrier may be achieved. Further control, may be achieved with an electrostatic field, where the fluids differ as to their composition and ionic strength.
  • a barrier By irradiating or heating at the intersection, or merely bringing the two media together, depending on the nature of the initiator, a barrier will be created at the intersection.
  • Various monomers to be used to form polymers or various preformed polymers may be employed, where metal atoms or ions are employed, such as Ag, Fe, Cu, Ni, Mg, Cr, etc., which are readily chelated and provide for the passage of electrical current in the polymer.
  • These polymeric barriers may have the metal present when introduced into the channel or the metal may be added to the polymer later, by introducing the metal into the channel where it is transported to the barrier and captured by the barrier.
  • Various functionalities may be employed for capturing the metal, such as di- or higher order imidazoles, carboxy groups, amino groups, mercapto groups, sulfinic acids, oximino, etc. individually or in combination.
  • Metals may be present initially, using metallocenes, chelates, and the like. When the barrier is to be removed an electric current may be applied to the barrier which will destroy the barrier, leaving the channel free.
  • a viscous solution in channels or reservoirs adjacent to the area where the barrier is to be introduced. This serves to minimize hydrodynamic flow in the channels during polymerization.
  • Various inert thickening agents may be used, such as hydroxyethylcellulose, agarose, poly(vinyl alcohol), poly(vinyl alcohol/acetate), sucrose, etc. 6
  • the barrier is then created at the intersection by using a local agent which induces gellation or solidification.
  • a local agent which induces gellation or solidification.
  • particles may be used, which expand and contract with a change in a variety of conditions. The particles will generally be small enough to readily flow in the channel, varying in dry size from about 0.1 to 50 ⁇ m, where the matrix for the magnetic material can fuse to form a continuous barrier. If one wished to form a barrier between a side channel and a main channel, the particles would be put into the side channel in a fluid stream and extend to about the intersection.
  • the main channel would then be filled with a medium which would make the particles swell.
  • the medium behind the swollen particles would then be removed in any convenient manner.
  • the fluid in the side channel may be withdrawn using an absorbent paper or cloth.
  • the fluid from the main channel is withdrawn and replaced with a different medium, which is now blocked from entering the side channel.
  • Barriers may be created by tilling the capillaries with a buffer and pumping a solution of a gel forming agent into the main capillary while maintaining the temperature of the device above the gel transition temperature. Intrusion of the gel forming agent into a side capillary can be controlled by pressure applied through electroosmotic or other forces. The device is then cooled causing a gel to form in the main capillary and in a predetermined length of a side capillary. Application of sufficient electrical potential along the length of the main capillary will cause localized heating and melting of the gel leaving the gel only in the side capillary.
  • the main capillary can then be flushed free of the gel forming agent.
  • the gel barrier may be removed from the side capillary by heating the gel using thermal or electrostatic heating and then removed.
  • Compositions such as agarose, by itself or in combination with other polymeric compositions may be employed to modify the nature of the barrier.
  • the composition would be treated to form the barrier.
  • the composition would be treated to form the barrier.
  • photoinitiated polymerization one would fill the capillaries with a polymerizable medium and irradiate the medium at the intersection to form the barrier, using masks or other means to localize the irradiation to the position where the barrier is to be placed.
  • the polymerizable medium may then be removed by any convenient means, such as electroosmosis, washing out the polymerizable medium with a wash medium, high ?? enerty ??
  • the polymerizable medium will require a monomer and may also require an initiator.
  • various conventional polymerization initiation systems may be employed, such as APS (ammonium persulfate) and TEMED (tetramethylene diamine), methylene blue and toluidine sulfate, riboflavin and TEMED, methylene blue, methylene blue and TEMED, methylene blue/sodium toluene sulfate/DPIC (diphenyl iodonium chloride), riboflavin 5'-phosphate, riboflavin 5'-phosphate/TEMED/DPIC, hydrogen peroxide/potassium persulfate, l-[4-(2'-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-l- propane-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-l-phenylpropan-l- one, etc.
  • APS ammonium persulfate
  • TEMED tetramethylene diamine
  • the barrier may be abolished, while leaving the barrier composition in the device, the barrier composition may be removed through a port or channel or other convenient means, depending on the configuration of the device, the nature of the composition and the other agents present in the device.
  • the barrier composition may be part of the medium used in the channel. In other instance it may be dissolved in a solvent and the solvent withdrawn, the medium may be melted by an elevated temperature, a change in pH or ionic strength may serve to contract the barrier, and the like. Once the barrier had been abolished, one may proceed with the operations of the device involving the segregated channel or chamber.
  • the subject devices find a variety of uses in being able to separate components of a mixture by charge and/or size, perform chemical reactions, diagnostic assays, nucleic acid and protein sequencing, identification of cell species, receptors and the like, using intact or fragmented cells or cell walls or membranes, inhibit the passage of particles, serve as a source for a reagent allowing for reactions on or at the barrier, do biologically active compound screening, particularly drug screening using particular targets and candidate drugs or other biologically active compounds, etc.
  • capillaries may be used in combination with an electrical field for moving entities from one site to another, where the different operations may be performed.
  • the barrier may serve as a source of a reagent, where the monomer may carry the reagent, the reagent may react with the barrier so as to be covalently bonded to the barrier, the gel may be reacted with the reagent prior to its introduction at the barrier site, or particles carrying the reagent may be blocked from flowing past the barrier, so that the reagent is on the particles at the barrier site.
  • the barrier may serve not only as a passive restraint, but also as an active participant in the operation being carried out by the device.
  • sbp specific binding pair
  • sbp members examples include ligands and receptors (which includes antibodies, both naturally occurring and synthetic, and cell surface receptors), enzymes and their substrates and inhibitors, sugars and lectins, cyclic hosts (e.g. paracyclophanes, cyclodextrins, etc.), homologous nucleic acid sequences, and ligand guests, chelating compounds and metalloorganics, etc.
  • ligands and receptors such as blotin and avidin or strepavidin, antibodies and their ligands, exemplified by digoxin and antidigoxin, fluorescein and antifluorescein, green fluorescent protein and anti(green fluorescent protein), etc.
  • the barrier may serve to concentrate a component of a sample.
  • particles comprising oligonucleotides may be combined with a denatured DNA sample or an RNA sample, under stringent hybridization conditions. Only those sequences in the sample which have a sequence at least substantially homologous to the oligonucleotide will become bound to the particles.
  • the sample medium may then be moved electrostatically through a barrier containing channel, where the particles will be concentrated at the barrier and the residual
  • the conditions at the barrier may then be changed to release the captured DNA.
  • the conditions may be such as to also remove the barrier, e.g. heat, which melts the barrier and the DNA releasing the captured DNA.
  • the captured DNA may then be moved to a sequencing gel in a capillary, used for transcription in a cellular lysate containing the necessary factors for transcription, expanded by PCR, copied to provide dsDNA and inserted into a plasmid, or many other possible operations.
  • the deterred particles instead of using the deterred particles as a source of a reagent, one may use the polymer.
  • Agarose may be linked or covalently bonded with an sbp or an acryl monomer may have an sbp.
  • blotin may be linked to the agarose or linked to the acryl group through the carboxy group.
  • the barrier would then have biotin available for binding to its receptor, avidin or strepavidin.
  • the reverse could also be true where the avidin is bound to the barrier and will bind to biotin in the medium.
  • Antibodies to a compound(s) of interest could be conjugated to avidin and the conjugate added to a sample.
  • the compounds) of interest could be an enzyme, a receptor, or a small organic molecule drug.
  • the antibodies would bind to any compounds) of interest in the sample and then be directed electrokinetically down the channel to the conjugated barrier, where the antibody and its ligand would be captured.
  • the enzyme could then be assayed, released by changing the ionic strength and/or temperature at the site of the barrier, or the like.
  • the fluid at the barrier could then be moved as a slug, where the enzyme would be highly concentrated in a very small volume.
  • the released enzyme could then be assayed, used in a reaction, where the enzyme could be used to screen drugs as antagonists or substrates, or combined with other enzymes to perform a series of enzymatic reactions.
  • the barrier could also be used in performing immunoassays. For example, one could bind avidin to the barrier. At a port to the channel in which the barrier has been introduced, if one is measuring an antigen, one would add the sample and antibody conjugated to biotin and antibody conjugated to a fluorescent molecule or enzyme, where the antibodies bind to the antigen at different epitopic sites. The sample medium is then transferred electrokinetically to the barrier where the components of the sample medium flow through the barrier. The antibodies conjugated to biotin will be captured, but the antibodies conjugated to the fluorescent molecule will only be captured to the extent that antigen is present, by the antigen acting as a bridge or sandwich between the two differently conjugated antibodies.
  • the fluorescent label one would irradiate the barrier with excitation light and read the level of fluorescence.
  • the enzyme one would electrokinetically move a substrate to the barrier, where the product of the enzymatic reaction is chemiluminescent of fluorescent. Because one can make the area of the barrier very small, one concentrates the signal in a small area, providing for high sensitivity.
  • a redox catalyst bonded to the barrier composition. If one has a reagent which is oxidatively labile when in the reduced form, one can pass a slug of the oxidized form through the barrier, where it will be reduced and then move the reduced reagent to a reaction chamber in conjunction with other reagents for performing a reaction on the reduced form of the reagent.
  • the barriers provide extraordinary flexibility in their use, serving a passive mechanical role of impeding the movement of particles, including cells, organelles, and other aggregations of molecules, and polymeric particles, and molecules or may serve as an active role in being one component of a chemical operation.
  • the microfluidics device 10 depicted in Fig. 1 is a plan view.
  • the device which has been previously described in the literature, as indicated above, has a base plate with a number of features to be described and a cover plate, where the features have communication to the atmosphere and to electrodes.
  • the channels are of capillary dimensions, where the wells and chambers may have from 2 to 20 times the dimensions of the capillaries.
  • the device has a main channel 12, with a first port 14 and a second port 16, into which electrodes 18 and 20 intrude to provide an electrical field across the main channel as well as with the other electrodes for controlled movement of particles (includes molecules, small particles, aggregations of molecules, such as cells, organelles, etc.) through the channels of the device.
  • a medium which may be an electrophoretic medium, buffer or polymeric solution, which find use for transporting particles by electroosmostic flow or electrophoretically, providing electrophoretic separation, or other operation, as appropriate.
  • the same or other media may be in the other channels.
  • the side channels 22 and 24 are referred to as upper to the extent that the flow of fluid in the main channel 12 flows in the direction from port 14 to port 16.
  • Upper side channels 22 and 24 have ports 26 and 28 for receiving electrodes 30 and 32, respectively, and components for performing the operations associated with the use of the device 10.
  • the upper side channels 22 and 24 are open to the main channel 12, so that fluid may move between the channels.
  • side chamber 34 Along main channel 12 in the direction of flow is side chamber 34, having an inlet conduit 36 with port 38 and electrode
  • the main channel 12 comprises a reaction chamber which communicates with lower channel 50.
  • Lower channel 50 has port 52 and is connected with side channel 54, which has port 56. Electrodes 58 and 60 intrude into ports 52 and 56, respectively, to provide an electrical field with each other and the other electrodes when activated.
  • Channel 50 is constricted and the constriction is blocked by a wall 62 of expanded gel particles. The gel particles may be melted and are of an innocuous composition which does not interfere with the assay mixture.
  • Main channel 12 terminates in waste well 64, which has port 16 into which electrode 20 extends to provide the main electrical field along the main channel.
  • An assay may be carried out with the subject device, where the sample is introduced into port 26 and a first buffer reagent into port 28 and the two streams moved into the main channel to mix by means of first activating electrodes 30 and 20 and then activating electrodes 32 and 20.
  • the sample and reagent are allowed to mix and the mixture moved into juxtaposition to conduit 42.
  • the barrier 46 is removed by photodegradation.
  • a second reagent is introduce ⁇ into the main channel from chamber 34 by means of electrodes 38 and 20 and the second reagent allowed to react with the mixture.
  • the assay mixture is moved to chamber 48.
  • the composition used to form the gel wall 62 may be removed through side conduit 54 and port 56, using electrodes 58 and 20.
  • FIGs. 2A-D are diagrammatic views of the process for creating a wall.
  • a portion of a device 100 is shown having a major channel 102 and a side channel 104.
  • Side channel 104 has port 106 into which electrode 108 intrudes.
  • Side channel 104 has a constricted opening 1 10 at the juncture to the major channel 102.
  • a fluid composition 112 is introduced into side channel 104 through port 106 and moved to the constricted opening 110 by means of an electrical field between electrode 108 and a second electrode, not shown.
  • the fluid composition has a liquid carrier and gel particles which expand upon a change in pH, ionic strength or the like, and will retain the expanded state for an extended period of time.
  • a fluid 114 is introduced into major channel 102, which his the required property for expanding the gel particles 116 to provide a substantially liquid impermeable barrier I 1 8 at the constricted opening 110.
  • Fig. 2B a fluid composition 112 is introduced into side channel 104 through port 106 and moved to the constricted opening 110 by means of an electrical field between electrode 108 and a second electrode, not shown.
  • the fluid composition has a liquid carrier and gel particles which expand upon a change in pH, ionic strength or the like, and will retain the expanded state for an extended period of time.
  • a fluid 114 is introduced into major channel 102, which his the required property for expanding
  • the liquid 114 is removed from the major channel 102 and the fluid composition 112 is removed from the side channel 104 with a syringe through port 106, with air passing through the barrier 118 or through another channel, not shown.
  • the gel may be melted with heat to permit liquid communication between side channel 104 and major channel 102.
  • Figs. 3A-D are diagrammatic views of an alternative process for creating a barrier between two channels.
  • a portion of a device 200 is shown having a major channel 202 and a side channel 204.
  • Side channel 204 has port 206 into which electrode 208 intrudes.
  • Side channel 204 has a second port 210.
  • Extending through major channel 202 and side channel 204 is an inert liquid 212.
  • a monomeric fluid composition 214 is introduced into side channel 204 through port 206 and moved to the intersection 216 between the main channel 202 and the side channel 204 by control of the volume of the monomeric fluid composition 214 and mild pressure.
  • the monomeric fluid composition 214 is comprised of a monomer and a photolytically active initiator.
  • the fluid 214 at the intersection 216 is irradiated by means of LED 218 to polymerize and form an impermeable barrier 220 at the intersection 216.
  • the fluid composition 212 is removed from the major channel 202 and the monomeric fluid composition 214 is removed from the side channel 204 with a syringe through port 206.
  • the polymeric barrier 220 When a material is to be introduced into the major channel 202 through side channel 204, the polymeric barrier 220 may be melted with heat to permit liquid communication between side channel 204 and major channel 202 or may be retained and allow for transport of particles through the barrier under the influence of an electrical field.
  • Figs. 4A-D use of superparamagnetic beads is depicted as a fragment of a microfluidic device.
  • the device 300 has main channel 302, side channel 304 and magnetic bead reservoir 306 in which resides magnetic beads 308.
  • Side channel 304 had port 310 and magnetic bead reservoir 306 has port 312 for charging and removal of beads.
  • the magnetic beads could be enclosed during the fabrication of the device, particularly if the device is to be used only once or a few times and then thrown away.
  • Buffer 314 extends throughout the device.
  • the magnetic beads 308 are held in the magnetic bead reservoir and the main channel 302 and the side channel 304 are in fluid communication.
  • the magnetic beads 308 have been moved into channel 304 to form barrier 316.
  • the buffer 314 has been removed from the side channel 304 by means of a syringe through port 310 and replaced with cells 318 and lysate buffer 320.
  • the magnetic beads are returned to the magnetic bead reservoir 306 to restore communication between the main channel 302 and the side channel 304.
  • the components of the lysate medium may now be electrostatically moved to the main channel for further operations.
  • Example A Production of microfluidic chips.
  • Glass chips were fabricated according to the protocol of Simpson et al., PNAS USA 95, 2256-61, 1998. Briefly, clean 4" diameter, 1.1 mm thick borofloat glass substrates (Precision Glass and Optics, Santa Ana, CA) were coated with a -1500 Angstroms thick layer of amorphous silicon using plasma enhanced chemical vapor deposition. Substrates were coated with photoresist (Shipley 1818) by spinning at 6000 rpm for 30 sec and then baked at 90°C for 25 min. Channel patterns were transferred to the substrates using photolithography and the exposed amorphous silicon was removed in a CF, plasma.
  • channels were formed by wet chemical etching of the glass in a cone HF solution.
  • the amorphous silicon acts as an etch mask to protect unexposed regions of the substrate from attack by HF.
  • the photoresist was removed in a H 2 SO 4 :H 2 O 2 solution (3: 1) and the remaining amorphous silicon was etched by a CF, plasma.
  • the final channel cross-section was trapezoidal; 50 :m deep, 120 :m wide at the top of the channel and 50 :m wide at the bottom of the channel. Reservoir holes were drilled into the etched chip using a 1.2 mm diamond- tipped drill bit.
  • a second 4" substrate was thermally bonded to the etched substrate to seal the channels.
  • reservoirs 1 and 3 are buffer reservoirs
  • 3 is a waste reservoir
  • 4 is a sample reservoir.
  • a stock solution containing acrylamide and methylene bisacrylamide (BIS) was prepared at 20.8% T and 3.33% C in 100 ⁇ M phosphate buffer, pH 6.76.
  • %T is a measure of the total monomer concentration; in this case, the grams of acrylamide and BIS added to lOOmL of buffer.
  • %C is a measure of the crosslinker concentration; in this case, the weight % of BIS relative to the combined mass of acrylamide and BIS).
  • To 1 mL of this stock solution was added 0.333 mL of lOOmM phosphate buffer, pH 6.76. The solution was degassed under a 25 in Hg vacuum for -30 min.
  • the chip was covered with black duct tape, such that only arms leading to reservoirs 2 and 4 were visible.
  • the chip was placed under a hand-held UV-365 source (UVP UVL-56 (6W, Hg vapor, 1350 :W/cm 2 at 3 in) and illuminated for 20 min.
  • the tape was removed and reservoir 1 was washed with 10 :L of 1 X TBE.
  • a suspension of -0.1% superparamagnetic particles (carboxylated JSR Co.) in 1 X TBE was added to reservoir 1 and 500 V applied to reservoir 3. Under the imposition of the voltage, the beads migrated out of reservoir 1 and accumulated against the interface of buffer and gel immediately adjacent to the channel intersection.
  • the solution was degassed and 0.5 ⁇ L TEMED, 10 ⁇ L 0.1 mM riboflavin, and 25 ⁇ L 1 mM DPIC added to 0.99 mL of the monomer/sucrose solution.
  • a MonoKote- sealed chip was filled with the solution and 2% HEC placed into each reservoir to block hydrodynamic flow. Channel 6 was masked with black tape, leaving channel 5 exposed The chip was illuminated under the UV source overnight. The contents of the reservoirs were replaced with 1 X TBE and the chip was preelectrophoresed until the current reached steady- state.
  • a fluoresceinated DNA marker (Fluorescein Low Range DNA Standard, BioRad, Richmond, CA) was loaded in reservoir 4 and injected into the separation channel. The separation was monitored approximately 1 cm down-stream from the channel intersection. All fragments were resolved except for the 220 hp and 221 hp which comigrated.
  • Example 3 Polymerization of temperature-sensitive polymer in a chip.
  • a solution of 15%T, 3%C N-isopropyl acrylamide/BIS in 100 mM phosphate buffer was degassed for 30 min under a vacuum of 25 in Hg.
  • To 0.9 mL of this solution was added 0.1 mL of 0.1 mM riboflavin and 0.5 ⁇ L TEMED.
  • a MonoKote-sealed plastic chip was filled with the monomer/photoinitiator solution by capillary action and each reservoir was filled with 10 ⁇ L of the same solution.
  • a solution of 2% HEC was added to reservoirs 2, 3, and 4 to minimize hydrodynamic flows during polymerization. The chip was placed on the 16
  • a solution of 2% low-melt agarose (BioRad, Richmond, CA) was prepared by heating in 1 X TBE in a microwave. A plastic chip sealed with a cover plate was heated briefly under a hair dryer. The chip was filled with 1 X TBE and the hot agarose solution was loaded into one reservoir. A vacuum was applied to a second reservoir to pull the agarose through the channel. After allowing the chip to cool, superparamagnetic beads were electrophoresed against the agarose in the structure. The agarose gel blocked the migration of the beads.

Abstract

Microfluidic devices are provided where barriers are introduced between different compartments of the device to prevent fluid flow between the two compartments. Different materials and methods are employed for the introduction and removal of the barriers, including reversible gel particle expansion, reversible gellation, in situ polymerization, magnetic beads, and the like. In this way mixing of agents may be temporally controlled during the operation of the device, where the barriers may be used in a passive manner or as an active agent involved in the operation being performed in the device.

Description

MULTICHANNEL CONTROL IN MICROFLUIDICS
INTRODUCTION Technical Field
The field of this invention is microfluidics, using an electrical field to move particles through capillaries.
Background The use of electrical fields to separate particles in complex mixtures into their component parts is well established. Gel electrophoresis, isotachophoresis and isoelectric focusing find expanding use as the demands of biology and medicine increase and our abilities to isolate and create new chemical entities expands. The use of electrical fields is also employed for the movement of small volumes in capillaries, where components of a medium may be moved within or between channels in a capillary device. Microfluidics allows for the manipulation of small volumes in a variety of separation, concentration and purification systems, which are commonly performed on a macro scale. However, as interest has increased in using increasingly smaller amounts of material, due to the small amount of sample available, the interest in accelerating the time required for a reaction to occur, the need to perform a large number of different operations on a single sample or multiple samples, and the like has led to the development of microfluidics.
Microfluidics employs capillaries as the channel in which various activities occur, where electrical Fields or pressure differentials are created in the channels to move mixture components from site to site. These new miniature systems have expanded on the electrophoretic capabilities in providing chemical laboratories on a chip, where one may have a plurality of intersecting channels, reagent chambers and the ability to change the environment at individual sites or for the entire device. The present miniature devices are not limited to separation, but allow for chemical reaction, affinity binding, diagnostic assays, identification of entities, the manipulation of very small volumes for any purpose and other operations.
Devices having multiple intersecting channels are described in U.S. Patent no. 5,858,188. In these devices various compositions may be introduced into a specific channel, e.g. a main channel or branched channel, where one wishes to perform independent operations. Thus, one may wish to isolate particular regions of what may be called the movement area, that is the area in which movement of sample, reagents and media occurs. In one example, one may wish to introduce a particular medium in the main channel without the medium entering a branched channel. One may wish to put into chambers various reactants, which should not mix with other materials present in other channels. In some instances, one may wish to have a reaction proceed, followed by the addition of a reagent, where the device is originally charged with the reagent and at the appropriate time the reagent is introduced into the reaction chamber. With the use of particles, one may wish to impede the movement of particles at various times or isolate the particles to a particular compartment in the movement area. These and other Fig. 5 is a diagrammatic view of a channel layout.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Microfluidic devices are provided where barriers to flow are introduced at intersections between functional areas of the device, which barriers are porous and allow for movement of chemical entities under the influence of an electrical field or may be removed. The barriers may take a variety of forms: formed of a polymeric composition, which may be preformed or formed in situ magnetic beads. The microfluidic devices have a plurality of functional areas comprising at least one capillary channel or trough and may have reagent chambers, where the cross-sectional dimensions of the chamber will be greater than the cross- sectional dimensions of the channel, which area may be referred to as the "movement area." The microfluidic devices arc used- to manipulate particles, which may be charged or uncharged, and include individual entities, such as ions and molecules, as well as aggregates of entities, such as complexes involving two or more molecules, large aggregates, such as organelles, cells, viruses, or other entities, usually less than about lμ.
The microfluidic devices will usually be small solid substrates, which may be referred to as chips. The substrate may be any convenient material, including plastics, e.g. acrylics, glass, silicon, ceramic, or other convenient material, which may be fabricated. The devices may be long sheets or slabs comprising numerous fluidic systems. However, generally, the largest dimension will be less than about 100cm, usually less than about 50cm and not less than about 1cm. Depending on the particular function of the device, the device may range from about 10 to 20 cm or longer, for example for DNA sequencing, or from about 2 to 10 cm, for other applications, such as drug screening. The thickness of the device may be varied and may involve a number of different layers, particularly where temperature control is provided. Generally the device will be at least about 10 μm high or thick and not more than about 50 mm, usually not more than about 20 mm. The channels will usually have cross-sections in the range of about 25 to 2000 μm2, more usually in the range of about 100 to 500 μm , although in some instances the channels may be larger or smaller by an order of 10. Channels may be of varying length, usually be at least about 5 μm and may run substantially the length of the device, usually being less than about 100 cm, more usually being less than about 50 cm, frequently less than about 15 cm, where the channel maybe interrupted by one or more chambers. Again, the length of the channel will generally be determined by the function for which the device is being used. The channel may be straight, angled, tortuous, or any path, depending on the nature of the device and its use.
Generally, a cover will be used to enclose the channels and chambers, which cover may be a film, plate, or the like, and may provide ports for introduction and removal of fluids, provide for electrodes to contact the media in the channels and chambers, may also serve to control the environment as specific sites, e.g. temperature, provide access to light for introducing radiation and/or observing radiation, and the like. Alternatively, the substrate may provide one or more of these features. In some instances ports and electrodes may be along the edges of the device.
The device may have a single microfluidic system or a plurality of microfluidic systems, which may be run concurrently or independently. The number of fluidic systems will be at least one and not more than about 5,000, usually not more than about 1,000. The device will usually include one or more source and/or waste wells, which may provide tile fluid for the channel, particularly for separations, and accommodate the waste from one or more systems or a single system may have a plurality of source and waste wells, generally from about 1 to 10, usually from about 1 to 5 of each. Alternatively, wells may be external to the device and feed and receive fluids through conduits connected to the ports.
The electrodes can be formed photolithographically to be in contact with the media at specific positions in the channels and, when appropriate, in the chambers and wells.
Alternatively, the electrodes may be individually positioned exterior to the device and extend into a capillary or chamber through a port or a combination of the two methods may be employed. The device will usually be used with an automated instrument, which may provide the electrodes or contacts to the electrodes. By having electrodes at various sites in the system, entities may be moved from position to position to perform the diverse operations which are feasible with the subject devices. The barriers may be of any length above a minimum of about 0.05 μm. Usually the barriers which will be employed will generally be at least about 0.1 mm, more usually at least about 0.2 mm, and may be much larger, usually not exceeding the length of a channel, usually not more than about 1 cm, more usually not exceeding 0.5 cm, and preferably not exceeding 0.25 cm, depending on the nature of the composition of the barrier, the function of the barrier, the manner of formation, and the like.
In utilizing the devices for introduction of barriers, one or more capillaries or chambers may be filled with the agent for producing the barriers. In one embodiment, the composition will be a free-flowing composition comprised of a material, which may have one or more components, which will produce a physical barrier to fluid flow. The composition may have a monomer, which by itself or in combination with other components, will polymerize, particularly under photoinitiation, or a composition which will gel or solidify by a change in conditions, e.g. temperature, pH, solvent, ionic strength, etc. Various monomers may be employed, including monomers which find use in gel electrophoresis, such as acryl (including methacryl) monomers, particularly acrylamides, where the nitrogen may be substituted, thermo-reversible polymers, where heating or cooling results in a change in their physical properties, such as acrylic polymers, e.g. hydroxyalkylacrylamides and - methacrylamides, hydroxyalkylacrylates and -methacrylates, silicones, sulfonated styrenes, urethane oligomers, polysaccharides, e.g. agarose and hydroxyalkylcellulose, etc. See particularly, U.S. Patent nos. 5,569,364 and 5,672,297. Polymeric particles may be employed where a change in the medium results in the swelling or shrinking of the particles.
Of particular interest are acrylamides which are polymerized with a photoinitiator and the composition may include a cross-linker, which cross-linker is stable or labile, particularly labile, more particularly photolytically labile at a shorter wavelength than the wavelength used for photoinitiation. Alternatively, the cross-linker may be thermally or chemically labile or the polymer may be soluble in a solvent which can be accommodated by the system.
Functional groups which may be employed include azo, disulfide, peroxide, -diketo, etc. Thus, non-cross-linked and cross-linked polymers are envisioned. After introducing the barrier- forming composition into the appropriate areas of the system, the barriers may then be formed at the desired sites. By using masks, which may be photolithographic masks, ink designs on the surface of the device, focused light or other means for limiting the radiation to the site of interest, formation of the barrier will be restricted to the area being Irradiated. For example, if one wishes to protect side channels from leakage of the medium in a main channel, formation of the barrier is performed at the sites of intersection of the main channel. By controlling the pressure and/or volume of the fluid in the two different channels, control of the site of the barrier may be achieved. Further control, may be achieved with an electrostatic field, where the fluids differ as to their composition and ionic strength. Thus, one may control the path of the composition, by the site at which the composition is introduced and controlling the volume of the composition, using an electrical field by including charged entities in the fluid, occupying a channel with a composition, so that the barrier-forming composition is inhibited from entering the channel, and the like. Alternatively, one may have monomer in one channel and initiator in another channel which intersects with the first channel. The monomer and initiator will diffuse together at the intersection. By irradiating or heating at the intersection, or merely bringing the two media together, depending on the nature of the initiator, a barrier will be created at the intersection. Various monomers to be used to form polymers or various preformed polymers may be employed, where metal atoms or ions are employed, such as Ag, Fe, Cu, Ni, Mg, Cr, etc., which are readily chelated and provide for the passage of electrical current in the polymer.
These polymeric barriers may have the metal present when introduced into the channel or the metal may be added to the polymer later, by introducing the metal into the channel where it is transported to the barrier and captured by the barrier. Various functionalities may be employed for capturing the metal, such as di- or higher order imidazoles, carboxy groups, amino groups, mercapto groups, sulfinic acids, oximino, etc. individually or in combination.
Metals may be present initially, using metallocenes, chelates, and the like. When the barrier is to be removed an electric current may be applied to the barrier which will destroy the barrier, leaving the channel free.
It may be desirable to include a viscous solution in channels or reservoirs adjacent to the area where the barrier is to be introduced. This serves to minimize hydrodynamic flow in the channels during polymerization. Various inert thickening agents may be used, such as hydroxyethylcellulose, agarose, poly(vinyl alcohol), poly(vinyl alcohol/acetate), sucrose, etc. 6
Where one controls the path of the composition by the volume, one introduces the barrier-forming composition at an appropriate port and allows the composition to move to the intersection at which a barrier is to be formed. Depending on the nature of the composition, the barrier is then created at the intersection by using a local agent which induces gellation or solidification. For example, particles may be used, which expand and contract with a change in a variety of conditions. The particles will generally be small enough to readily flow in the channel, varying in dry size from about 0.1 to 50μm, where the matrix for the magnetic material can fuse to form a continuous barrier. If one wished to form a barrier between a side channel and a main channel, the particles would be put into the side channel in a fluid stream and extend to about the intersection. The main channel would then be filled with a medium which would make the particles swell. The medium behind the swollen particles would then be removed in any convenient manner. By having a port at about the barrier site, which may be sealable, the fluid in the side channel may be withdrawn using an absorbent paper or cloth. One may then fill the side channel with the medium which maintains the particles in a swollen condition. To provide improved blockage, one may constrict the side channel at the intersection with the main channel, so as further enhance the barrier. The fluid from the main channel is withdrawn and replaced with a different medium, which is now blocked from entering the side channel.
Barriers may be created by tilling the capillaries with a buffer and pumping a solution of a gel forming agent into the main capillary while maintaining the temperature of the device above the gel transition temperature. Intrusion of the gel forming agent into a side capillary can be controlled by pressure applied through electroosmotic or other forces. The device is then cooled causing a gel to form in the main capillary and in a predetermined length of a side capillary. Application of sufficient electrical potential along the length of the main capillary will cause localized heating and melting of the gel leaving the gel only in the side capillary.
The main capillary can then be flushed free of the gel forming agent. As desired, the gel barrier may be removed from the side capillary by heating the gel using thermal or electrostatic heating and then removed. Compositions such as agarose, by itself or in combination with other polymeric compositions may be employed to modify the nature of the barrier.
With an electrical field, one can move the medium through the various component domains of the system. At each intersection at which a barrier is to be installed, the composition would be treated to form the barrier. For example, with photoinitiated polymerization, one would fill the capillaries with a polymerizable medium and irradiate the medium at the intersection to form the barrier, using masks or other means to localize the irradiation to the position where the barrier is to be placed. The polymerizable medium may then be removed by any convenient means, such as electroosmosis, washing out the polymerizable medium with a wash medium, high ?? enerty ?? irradiation, chemical treatment or using an absorbent medium at a port which would withdraw the polymerizable medium, or it combination of these and other methods. Alternatively, one may have a side channel into which one may draw the composition electroosmotically. The polymerizable medium will require a monomer and may also require an initiator.
Depending on the monomer, various conventional polymerization initiation systems may be employed, such as APS (ammonium persulfate) and TEMED (tetramethylene diamine), methylene blue and toluidine sulfate, riboflavin and TEMED, methylene blue, methylene blue and TEMED, methylene blue/sodium toluene sulfate/DPIC (diphenyl iodonium chloride), riboflavin 5'-phosphate, riboflavin 5'-phosphate/TEMED/DPIC, hydrogen peroxide/potassium persulfate, l-[4-(2'-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-l- propane-1-one, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methyl-l-phenylpropan-l- one, etc.
Alternatively, one may fill the main and other channels and chambers with a medium and then force the barrier-forming medium to an intersection using pressure and/or vacuum at the entry port of the barrier- forming medium or an another, directing the other medium out of the channel, until the barrier-forming medium has reached the intersection. At this time one forms the barrier and then removes the two media from the device.
Depending on the nature of the barrier medium, the barrier may be abolished, while leaving the barrier composition in the device, the barrier composition may be removed through a port or channel or other convenient means, depending on the configuration of the device, the nature of the composition and the other agents present in the device. In some instances, the barrier composition may be part of the medium used in the channel. In other instance it may be dissolved in a solvent and the solvent withdrawn, the medium may be melted by an elevated temperature, a change in pH or ionic strength may serve to contract the barrier, and the like. Once the barrier had been abolished, one may proceed with the operations of the device involving the segregated channel or chamber. The subject devices find a variety of uses in being able to separate components of a mixture by charge and/or size, perform chemical reactions, diagnostic assays, nucleic acid and protein sequencing, identification of cell species, receptors and the like, using intact or fragmented cells or cell walls or membranes, inhibit the passage of particles, serve as a source for a reagent allowing for reactions on or at the barrier, do biologically active compound screening, particularly drug screening using particular targets and candidate drugs or other biologically active compounds, etc. There is an extensive literature on the manner in which capillaries may be used in combination with an electrical field for moving entities from one site to another, where the different operations may be performed. The barrier may serve as a source of a reagent, where the monomer may carry the reagent, the reagent may react with the barrier so as to be covalently bonded to the barrier, the gel may be reacted with the reagent prior to its introduction at the barrier site, or particles carrying the reagent may be blocked from flowing past the barrier, so that the reagent is on the particles at the barrier site. In this way the barrier may serve not only as a passive restraint, but also as an active participant in the operation being carried out by the device. Of particular interest is the use of specific binding pair ("sbp") members, where one member of the sbp is bonded to the barrier. Examples of sbp members are ligands and receptors (which includes antibodies, both naturally occurring and synthetic, and cell surface receptors), enzymes and their substrates and inhibitors, sugars and lectins, cyclic hosts (e.g. paracyclophanes, cyclodextrins, etc.), homologous nucleic acid sequences, and ligand guests, chelating compounds and metalloorganics, etc. Of particular interest are ligands and receptors, such as blotin and avidin or strepavidin, antibodies and their ligands, exemplified by digoxin and antidigoxin, fluorescein and antifluorescein, green fluorescent protein and anti(green fluorescent protein), etc. The barrier may serve to concentrate a component of a sample. For example, particles comprising oligonucleotides may be combined with a denatured DNA sample or an RNA sample, under stringent hybridization conditions. Only those sequences in the sample which have a sequence at least substantially homologous to the oligonucleotide will become bound to the particles. The sample medium may then be moved electrostatically through a barrier containing channel, where the particles will be concentrated at the barrier and the residual
DNA flow through the barrier. The conditions at the barrier may then be changed to release the captured DNA. The conditions may be such as to also remove the barrier, e.g. heat, which melts the barrier and the DNA releasing the captured DNA. The captured DNA may then be moved to a sequencing gel in a capillary, used for transcription in a cellular lysate containing the necessary factors for transcription, expanded by PCR, copied to provide dsDNA and inserted into a plasmid, or many other possible operations. Instead of using the deterred particles as a source of a reagent, one may use the polymer. Agarose may be linked or covalently bonded with an sbp or an acryl monomer may have an sbp. For example, blotin may be linked to the agarose or linked to the acryl group through the carboxy group. The barrier would then have biotin available for binding to its receptor, avidin or strepavidin. The reverse could also be true where the avidin is bound to the barrier and will bind to biotin in the medium. One could then use the barrier to capture various agents to which biotin or avidin have been bound. Antibodies to a compound(s) of interest could be conjugated to avidin and the conjugate added to a sample. The compounds) of interest could be an enzyme, a receptor, or a small organic molecule drug. The antibodies would bind to any compounds) of interest in the sample and then be directed electrokinetically down the channel to the conjugated barrier, where the antibody and its ligand would be captured. The enzyme could then be assayed, released by changing the ionic strength and/or temperature at the site of the barrier, or the like. The fluid at the barrier could then be moved as a slug, where the enzyme would be highly concentrated in a very small volume. The released enzyme could then be assayed, used in a reaction, where the enzyme could be used to screen drugs as antagonists or substrates, or combined with other enzymes to perform a series of enzymatic reactions.
The barrier could also be used in performing immunoassays. For example, one could bind avidin to the barrier. At a port to the channel in which the barrier has been introduced, if one is measuring an antigen, one would add the sample and antibody conjugated to biotin and antibody conjugated to a fluorescent molecule or enzyme, where the antibodies bind to the antigen at different epitopic sites. The sample medium is then transferred electrokinetically to the barrier where the components of the sample medium flow through the barrier. The antibodies conjugated to biotin will be captured, but the antibodies conjugated to the fluorescent molecule will only be captured to the extent that antigen is present, by the antigen acting as a bridge or sandwich between the two differently conjugated antibodies. For the fluorescent label, one would irradiate the barrier with excitation light and read the level of fluorescence. For the enzyme, one would electrokinetically move a substrate to the barrier, where the product of the enzymatic reaction is chemiluminescent of fluorescent. Because one can make the area of the barrier very small, one concentrates the signal in a small area, providing for high sensitivity.
One may also use the barrier as a catalyst to perform a catalytic reaction in a small volume. For example, one may use a redox catalyst bonded to the barrier composition. If one has a reagent which is oxidatively labile when in the reduced form, one can pass a slug of the oxidized form through the barrier, where it will be reduced and then move the reduced reagent to a reaction chamber in conjunction with other reagents for performing a reaction on the reduced form of the reagent. One may use the barrier to define a site in the fluidic device. By using fluorescent particles which are introduced into the device, the fluorescent particles will travel through the device until the particles encounter the barrier. Depending on the number of particles introduced, one may have a very fine line of fluorescence or a thick line or something in between. The above illustrations are only a few of the operations possible by use of barriers.
The barriers provide extraordinary flexibility in their use, serving a passive mechanical role of impeding the movement of particles, including cells, organelles, and other aggregations of molecules, and polymeric particles, and molecules or may serve as an active role in being one component of a chemical operation. For further understanding of the invention, the drawings will now be considered. The microfluidics device 10 depicted in Fig. 1 is a plan view. The device which has been previously described in the literature, as indicated above, has a base plate with a number of features to be described and a cover plate, where the features have communication to the atmosphere and to electrodes. The channels are of capillary dimensions, where the wells and chambers may have from 2 to 20 times the dimensions of the capillaries. The device has a main channel 12, with a first port 14 and a second port 16, into which electrodes 18 and 20 intrude to provide an electrical field across the main channel as well as with the other electrodes for controlled movement of particles (includes molecules, small particles, aggregations of molecules, such as cells, organelles, etc.) through the channels of the device. In the main channel is a medium, which may be an electrophoretic medium, buffer or polymeric solution, which find use for transporting particles by electroosmostic flow or electrophoretically, providing electrophoretic separation, or other operation, as appropriate. The same or other media may be in the other channels.
As device 10 is depicted, it has two side upper channels 22 and 24 which face each other and provide a pathway intersecting with the main channel 10. The side channels 22 and 24 are referred to as upper to the extent that the flow of fluid in the main channel 12 flows in the direction from port 14 to port 16. Upper side channels 22 and 24 have ports 26 and 28 for receiving electrodes 30 and 32, respectively, and components for performing the operations associated with the use of the device 10. The upper side channels 22 and 24 are open to the main channel 12, so that fluid may move between the channels. Along main channel 12 in the direction of flow is side chamber 34, having an inlet conduit 36 with port 38 and electrode
40, and a constricted outlet conduit 42. At the intersection between the outlet conduit 42 and the main channel is a polymeric barrier wall 46. The polymeric barrier wall is comprised of a polymer, which will allow for the flow of liquid when under an electrical field, but will inhibit mechanical flow, when only under the influence of mild mechanical forces. The main channel 12 comprises a reaction chamber which communicates with lower channel 50.
Lower channel 50 has port 52 and is connected with side channel 54, which has port 56. Electrodes 58 and 60 intrude into ports 52 and 56, respectively, to provide an electrical field with each other and the other electrodes when activated. Channel 50 is constricted and the constriction is blocked by a wall 62 of expanded gel particles. The gel particles may be melted and are of an innocuous composition which does not interfere with the assay mixture.
Main channel 12 terminates in waste well 64, which has port 16 into which electrode 20 extends to provide the main electrical field along the main channel.
An assay may be carried out with the subject device, where the sample is introduced into port 26 and a first buffer reagent into port 28 and the two streams moved into the main channel to mix by means of first activating electrodes 30 and 20 and then activating electrodes 32 and 20. The sample and reagent are allowed to mix and the mixture moved into juxtaposition to conduit 42. The barrier 46 is removed by photodegradation. Then, a second reagent is introduce^ into the main channel from chamber 34 by means of electrodes 38 and 20 and the second reagent allowed to react with the mixture. After sufficient time for reaction, the assay mixture is moved to chamber 48. The composition used to form the gel wall 62 may be removed through side conduit 54 and port 56, using electrodes 58 and 20. A third reagent is transferred into the chamber 48 by means of the electrical field generated by electrodes 58 and 20 and the third reagent introduced into channel 50 through port 56 by means of the electrical field generated by electrodes 58 and 20. By having a third reagent that provides a detectable signal in proportion to the amount of a compound of interest in the sample, the detectable signal may now be read and the assay completed. Figs. 2A-D are diagrammatic views of the process for creating a wall. In Fig. 2A a portion of a device 100 is shown having a major channel 102 and a side channel 104. Side channel 104 has port 106 into which electrode 108 intrudes. Side channel 104 has a constricted opening 1 10 at the juncture to the major channel 102. In Fig. 2B a fluid composition 112 is introduced into side channel 104 through port 106 and moved to the constricted opening 110 by means of an electrical field between electrode 108 and a second electrode, not shown. The fluid composition has a liquid carrier and gel particles which expand upon a change in pH, ionic strength or the like, and will retain the expanded state for an extended period of time. In Fig. 2C, a fluid 114 is introduced into major channel 102, which his the required property for expanding the gel particles 116 to provide a substantially liquid impermeable barrier I 1 8 at the constricted opening 110. In Fig. 2D, after formation of the barrier 118, the liquid 114 is removed from the major channel 102 and the fluid composition 112 is removed from the side channel 104 with a syringe through port 106, with air passing through the barrier 118 or through another channel, not shown. When a material is to be introduced into the major channel 102 through side channel 104, the gel may be melted with heat to permit liquid communication between side channel 104 and major channel 102.
Figs. 3A-D are diagrammatic views of an alternative process for creating a barrier between two channels. In Fig. 3A a portion of a device 200 is shown having a major channel 202 and a side channel 204. Side channel 204 has port 206 into which electrode 208 intrudes. Side channel 204 has a second port 210. Extending through major channel 202 and side channel 204 is an inert liquid 212. In Fig. 3B a monomeric fluid composition 214 is introduced into side channel 204 through port 206 and moved to the intersection 216 between the main channel 202 and the side channel 204 by control of the volume of the monomeric fluid composition 214 and mild pressure. The monomeric fluid composition 214 is comprised of a monomer and a photolytically active initiator. In Fig. 3C, the fluid 214 at the intersection 216 is irradiated by means of LED 218 to polymerize and form an impermeable barrier 220 at the intersection 216. In Fig. 3D, after formation of the barrier 220, the fluid composition 212 is removed from the major channel 202 and the monomeric fluid composition 214 is removed from the side channel 204 with a syringe through port 206. When a material is to be introduced into the major channel 202 through side channel 204, the polymeric barrier 220 may be melted with heat to permit liquid communication between side channel 204 and major channel 202 or may be retained and allow for transport of particles through the barrier under the influence of an electrical field.
In Figs. 4A-D, use of superparamagnetic beads is depicted as a fragment of a microfluidic device. In Fig. 4A, the device 300 has main channel 302, side channel 304 and magnetic bead reservoir 306 in which resides magnetic beads 308. Side channel 304 had port 310 and magnetic bead reservoir 306 has port 312 for charging and removal of beads.
Alternatively, the magnetic beads could be enclosed during the fabrication of the device, particularly if the device is to be used only once or a few times and then thrown away. Buffer 314 extends throughout the device. The magnetic beads 308 are held in the magnetic bead reservoir and the main channel 302 and the side channel 304 are in fluid communication. In Fig. 4B, the magnetic beads 308 have been moved into channel 304 to form barrier 316. As illustrative, the buffer 314 has been removed from the side channel 304 by means of a syringe through port 310 and replaced with cells 318 and lysate buffer 320. After lysing the cells to form a lysate medium, as depicted in Fig. 4C, the magnetic beads are returned to the magnetic bead reservoir 306 to restore communication between the main channel 302 and the side channel 304. The components of the lysate medium may now be electrostatically moved to the main channel for further operations.
The following examples are offered by way of illustration and not by way of limitation.
EXPERIMENTAL
Example A. Production of microfluidic chips. a) Glass chips were fabricated according to the protocol of Simpson et al., PNAS USA 95, 2256-61, 1998. Briefly, clean 4" diameter, 1.1 mm thick borofloat glass substrates (Precision Glass and Optics, Santa Ana, CA) were coated with a -1500 Angstroms thick layer of amorphous silicon using plasma enhanced chemical vapor deposition. Substrates were coated with photoresist (Shipley 1818) by spinning at 6000 rpm for 30 sec and then baked at 90°C for 25 min. Channel patterns were transferred to the substrates using photolithography and the exposed amorphous silicon was removed in a CF, plasma. Finally, channels were formed by wet chemical etching of the glass in a cone HF solution. The amorphous silicon acts as an etch mask to protect unexposed regions of the substrate from attack by HF. After etching, the photoresist was removed in a H2SO4:H2O2 solution (3: 1) and the remaining amorphous silicon was etched by a CF, plasma. The final channel cross-section was trapezoidal; 50 :m deep, 120 :m wide at the top of the channel and 50 :m wide at the bottom of the channel. Reservoir holes were drilled into the etched chip using a 1.2 mm diamond- tipped drill bit. A second 4" substrate was thermally bonded to the etched substrate to seal the channels. Bonding was performed at 620°C in a vacuum furnace. b) Single-channel plastic chips were fabricated by injection molding as reported previously (McCormick, et al., Anal. Chem. 69, 2626-30, 1997), except that the chips were sealed with an acrylic cover plate by thermal bonding under pressure. Multichannel plastic chips were also fabricated by injection molding; however, the electroform used for the molding insert was prepared from an etched glass master. The multichannel chips were sealed by hot-roll lamination of a film (Top Flight MonoKote, Great Planes Model
Distributors, Champaign, IL) at 110°C±5°C in a clean room. Excess film was trimmed from the edges using a razor knife.
The channel design used in the following examples is shown in Fig. 5, with reservoirs 1 and 3 connected by channel 5 and reservoirs 2 and 4 connected by channel 6. For operation, reservoirs 1 and 2 are buffer reservoirs, 3 is a waste reservoir and 4 is a sample reservoir.
Example 1. Polymerization with riboflavin/TEMED
A stock solution containing acrylamide and methylene bisacrylamide (BIS) was prepared at 20.8% T and 3.33% C in 100 μM phosphate buffer, pH 6.76. (%T is a measure of the total monomer concentration; in this case, the grams of acrylamide and BIS added to lOOmL of buffer. %C is a measure of the crosslinker concentration; in this case, the weight % of BIS relative to the combined mass of acrylamide and BIS). To 1 mL of this stock solution was added 0.333 mL of lOOmM phosphate buffer, pH 6.76. The solution was degassed under a 25 in Hg vacuum for -30 min. 0.9 mL of the degassed solution was withdrawn and transferred to a microcentrifuge tube wrapped in aluminum foil. To the monomer solution was added 0.5 μL of TEMED and 100 μL of 0. ImM riboflavin. To fill the chip, 10 :L of the monomer/photoinitiator solution was added to reservoir 3 of a Monokote- sealed acrylic chip. After the channels had been filled by capillary action, 10 :L of the same solution was added to reservoir 1 followed by the addition of 10 :L of 2% hydroxycellulose (HEC) to each of reservoirs 2 and 4 and the solution in reservoir 3 was replaced by 2% HEC. The HEC solution serves to reduce undesired hydrodynamic flow in the channels during photopolymerization. The chip was covered with black duct tape, such that only arms leading to reservoirs 2 and 4 were visible. The chip was placed under a hand-held UV-365 source (UVP UVL-56 (6W, Hg vapor, 1350 :W/cm2 at 3 in) and illuminated for 20 min. The tape was removed and reservoir 1 was washed with 10 :L of 1 X TBE. A suspension of -0.1% superparamagnetic particles (carboxylated JSR Co.) in 1 X TBE was added to reservoir 1 and 500 V applied to reservoir 3. Under the imposition of the voltage, the beads migrated out of reservoir 1 and accumulated against the interface of buffer and gel immediately adjacent to the channel intersection.
Example 2. Polymerization with riboflavin/TEMED/DPIC/sucrose and electrophoresis of DNA An acrylamide/BIS solution was prepared at 6%T and 3%C in 1 X TBE containing
60wt % sucrose. The solution was degassed and 0.5 μL TEMED, 10 μL 0.1 mM riboflavin, and 25 μL 1 mM DPIC added to 0.99 mL of the monomer/sucrose solution. A MonoKote- sealed chip was filled with the solution and 2% HEC placed into each reservoir to block hydrodynamic flow. Channel 6 was masked with black tape, leaving channel 5 exposed The chip was illuminated under the UV source overnight. The contents of the reservoirs were replaced with 1 X TBE and the chip was preelectrophoresed until the current reached steady- state. A fluoresceinated DNA marker (Fluorescein Low Range DNA Standard, BioRad, Richmond, CA) was loaded in reservoir 4 and injected into the separation channel. The separation was monitored approximately 1 cm down-stream from the channel intersection. All fragments were resolved except for the 220 hp and 221 hp which comigrated.
Example 3. Polymerization of temperature-sensitive polymer in a chip. A solution of 15%T, 3%C N-isopropyl acrylamide/BIS in 100 mM phosphate buffer was degassed for 30 min under a vacuum of 25 in Hg. To 0.9 mL of this solution was added 0.1 mL of 0.1 mM riboflavin and 0.5 μL TEMED. A MonoKote-sealed plastic chip was filled with the monomer/photoinitiator solution by capillary action and each reservoir was filled with 10 μL of the same solution. A solution of 2% HEC was added to reservoirs 2, 3, and 4 to minimize hydrodynamic flows during polymerization. The chip was placed on the 16
objective stage of an inverted microscope and the channel intersection was illuminated from above by a Hg arc lamp through Koehler optics. The illuminated region was octagonal and the span was approximately 7 channel widths. The chip was allowed to stand for 30 min to ensure polymerization. The resulting gel was white, indicating that the exothermic polymerization had raised the temperature above the lower critical solution temperature of poly-N-isopropyl acrylamide.
Example 4. Formation of gel barrier using agarose.
A solution of 2% low-melt agarose (BioRad, Richmond, CA) was prepared by heating in 1 X TBE in a microwave. A plastic chip sealed with a cover plate was heated briefly under a hair dryer. The chip was filled with 1 X TBE and the hot agarose solution was loaded into one reservoir. A vacuum was applied to a second reservoir to pull the agarose through the channel. After allowing the chip to cool, superparamagnetic beads were electrophoresed against the agarose in the structure. The agarose gel blocked the migration of the beads.
It is evident from the above results, that the subject methods allow for the prevention of intermixing of different media, reagents, etc. allowing for retention of materials at one site while performing other operations and then being able to release a material at the appropriate time. In this way chips can be preloaded with reagents without there being mixing or subsequent interference with the process being performed in the device, until the time for the material to be introduced. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. All references cited herein are incorporated herein by reference, as if set forth in their entirety.

Claims

WHAT IS CLAIMED IS:
1. In a method for carrying out an operation with a microfluidic device employing electrical fields to move particles from one site to another in a movement area, the improvement which comprises: introducing a barrier to fluid flow in said movement area at a barrier site, where such barrier is removable by modifying the physical or chemical conditions of said barrier, or said barrier allows for transport of selected particles under an electrical field.
2. A method according to Claim 1, wherein said barrier is formed by the process of: delivering a liquid monomer composition through at least one of said compartments to the site for introduction of said barrier; applying a polymerizing agent at said barrier, whereby said monomeric composition polymerizes to a barrier in said movement area; and removing the unpolymerized monomeric composition from said at least one of said compartments.
3. A method according to Claim 1 , wherein said barrier is formed by the process of: delivering a fluid dispersion of expandable gel particles through at least one of said compartments to the site of introduction of said barrier; applying an expansion agent to said fluid dispersion at said barrier site, whereby said gel particles expand and form a barrier in said movement area; and removing said fluid dispersion containing unexpanded particles from said at least one of said compartments.
4. A method according to Claim 1 , wherein said barrier is comprised of magnetic beads and said barrier is introduced by moving said magnetic particles by means of a magnetic field, and said barrier is removed by moving said magnetic beads from said intersection by means of a magnetic field.
5. A method according to Claim 1 , wherein said device including an intersection between two compartments, and said barrier site is at said intersection.
6. A method according to Claim 1, further comprising removing said barrier from said barrier site.
7. A method for performing an operation in a microfluidic device comprising at least one compartment, said method comprising: introducing at a barrier site in said compartment a barrier to fluid flow and a reactant; introducing into said compartment at least one component of a sample for reaction with said reactant; and performing said operation in conjunction with said component reacting with said reactant.
8. A method according to Claim 7, wherein said reactant is a member of a specific binding pair and said component is a member of a specific binding pair (sbp), which becomes bound to said reactant.
9. A method according to Claim 8, wherein said reactant is a receptor or ligand sbp member and said component binds to an antibody conjugated to the reciprocal sbp member.
10. A method according to Claim 8, including the following steps of: combining a sample with an antibody conjugated to a member of an sbp reciprocal to an sbp member at said barrier site, wherein said sample is suspected of having a ligand binding to said antibody; moving said antibody electrokinetically to said barrier and allowing said antibody conjugate to bind to said reciprocal sbp member; and detecting any ligand bound to said barrier.
11. A method according to Claim 7, wherein said reactant is a redox catalyst.
12. A method according to Claim 7, wherein said compartment is a capillary channel.
13. A microfluidic device comprising at a barrier site a barrier to movement of beads, said barrier being removable by a change in physical or chemical environment of said barrier.
14. A microfluidic device according to Claim 13, wherein said barrier is a polymeric composition formed in situ.
15. A microfluidic device according to Claim 14, wherein said polymeric composition is an acrylic polymer.
16. A microfluidic device according to Claim 15, wherein said acrylic polymer is a thermoreversible acrylamide.
17. A microfluidic device according to Claim 13, wherein said barrier is a polymer composition which becomes flowable with a change in temperature.
18. A microfluidic device according to Claim 17, wherein said polymer composition is agarose.
19. A microfluidic device according to Claim 13, wherein said barrier is comprised of superparamagnetic beads.
20. A microfluidic device according to Claim 13, comprising a member of a specific binding pair bonded to said barrier.
21. A method for performing an operation in a microfluidic device comprising at least two intersecting compartments, and a removable barrier in at least one compartment, said method comprising: electrokinetically transporting particles to said barrier, wherein the flow of said particles is impeded by said barrier; performing said operation; and removing said barrier.
22. A method according to Claim 21 , wherein said particles are beads.
23. A method according to Claim 21 , wherein said particles are members of a specific binding pair.
24. A method according to Claim 21 , wherein said barrier is removed after said operation by changing the chemical or physical environment of said barrier.
EP00905943A 1999-02-03 2000-02-02 Multichannel control in microfluidics Withdrawn EP1157270A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11834499P 1999-02-03 1999-02-03
US118344P 1999-02-03
PCT/US2000/002746 WO2000046595A1 (en) 1999-02-03 2000-02-02 Multichannel control in microfluidics

Publications (1)

Publication Number Publication Date
EP1157270A1 true EP1157270A1 (en) 2001-11-28

Family

ID=22378003

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00905943A Withdrawn EP1157270A1 (en) 1999-02-03 2000-02-02 Multichannel control in microfluidics

Country Status (5)

Country Link
US (1) US20020153251A1 (en)
EP (1) EP1157270A1 (en)
JP (1) JP2002536640A (en)
CA (1) CA2361923A1 (en)
WO (1) WO2000046595A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109174788A (en) * 2018-08-19 2019-01-11 清华大学 Microballoon cleans chip and the microballoon cleaning device comprising it
WO2020078077A1 (en) * 2018-10-15 2020-04-23 京东方科技集团股份有限公司 Generation method and generation chip for micro sample

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3372800A (en) * 1999-02-23 2000-09-14 Caliper Technologies Corporation Manipulation of microparticles in microfluidic systems
AU6117700A (en) * 1999-07-23 2001-02-13 Board Of Trustees Of The University Of Illinois, The Microfabricated devices and method of manufacturing the same
JP2003522963A (en) * 2000-02-18 2003-07-29 アクララ バイオサイエンシーズ, インコーポレイテッド Multi-site reaction device and method
CN1231758C (en) 2000-10-19 2005-12-14 泰博特克公司 Method and device for manipulation of microcarriers for identification purpose
WO2003001633A2 (en) * 2001-01-26 2003-01-03 Northwestern University Method and device utilizing driving force to deliver deposition compound
US6875403B2 (en) * 2001-02-09 2005-04-05 Microchem Solutions Method and apparatus for reproducible sample injection on microfabricated devices
EP1418997B1 (en) * 2001-08-13 2010-04-28 The Board Of Trustees Of The Leland Stanford Junior University Bonded phase photopolymerized sol-gel column and associated methods
US7338760B2 (en) * 2001-10-26 2008-03-04 Ntu Ventures Private Limited Sample preparation integrated chip
US20030138819A1 (en) * 2001-10-26 2003-07-24 Haiqing Gong Method for detecting disease
EP1380835A1 (en) * 2002-07-08 2004-01-14 Siemens Aktiengesellschaft Analysis device for electrophoretic separation assays
GB0329220D0 (en) * 2003-12-17 2004-01-21 Inverness Medical Switzerland System
JP4750412B2 (en) * 2003-12-25 2011-08-17 モレックス インコーポレイテド Biologically derived molecules, dioxins and endocrine disrupting substance detection apparatus and detection method using the apparatus
ES2439225T3 (en) 2004-01-26 2014-01-22 President And Fellows Of Harvard College System and method for fluid supply
JP2005309140A (en) * 2004-04-22 2005-11-04 Toshiba Corp Method for manufacturing photomask, method for determining position of photomask defect correction, and apparatus for determining position of photomask defect correction
EP1824601B1 (en) 2004-10-18 2016-12-28 Life Technologies Corporation A device including a dissolvable structure for flow control
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US20090071828A1 (en) * 2005-03-23 2009-03-19 Squires Todd M Devices Exhibiting Differential Resistance to Flow and Methods of Their Use
JP2007085779A (en) * 2005-09-20 2007-04-05 Nissui Pharm Co Ltd Analysis method of biological substance using microchip and analyzing kit
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
CN101400445A (en) * 2006-03-15 2009-04-01 皇家飞利浦电子股份有限公司 Microelectronic device with controllable reference substance supply
CA2648099C (en) 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
WO2007150030A2 (en) * 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US20080101992A1 (en) * 2006-10-27 2008-05-01 Konica Minolta Medical & Graphic, Inc. Microchip and Microchip Inspection System
US20080245740A1 (en) * 2007-01-29 2008-10-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
WO2008098165A2 (en) 2007-02-09 2008-08-14 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
WO2008124639A2 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Poly (amino acid) targeting moieties
WO2008124634A1 (en) * 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
EP2011574A1 (en) * 2007-07-02 2009-01-07 STMicroelectronics (Research & Development) Limited Assaying device and method of transporting a fluid in an assaying device
AU2008314647B2 (en) 2007-10-12 2013-03-21 Massachusetts Institute Of Technology Vaccine nanotechnology
US8988881B2 (en) 2007-12-18 2015-03-24 Sandia Corporation Heat exchanger device and method for heat removal or transfer
KR101368178B1 (en) * 2008-01-07 2014-02-26 삼성전자주식회사 Method of fomring a filter in a fluid flow path in a microfluidic device
FR2930457B1 (en) * 2008-04-24 2010-06-25 Commissariat Energie Atomique PROCESS FOR MANUFACTURING RECONFIGURABLE MICROCHANNELS
US9005417B1 (en) 2008-10-01 2015-04-14 Sandia Corporation Devices, systems, and methods for microscale isoelectric fractionation
GB0818609D0 (en) 2008-10-10 2008-11-19 Univ Hull apparatus and method
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
WO2011035185A2 (en) * 2009-09-17 2011-03-24 The Brigham And Women's Hospital, Inc. A microfluidic device and uses thereof
US9795961B1 (en) 2010-07-08 2017-10-24 National Technology & Engineering Solutions Of Sandia, Llc Devices, systems, and methods for detecting nucleic acids using sedimentation
US8945914B1 (en) 2010-07-08 2015-02-03 Sandia Corporation Devices, systems, and methods for conducting sandwich assays using sedimentation
US8962346B2 (en) 2010-07-08 2015-02-24 Sandia Corporation Devices, systems, and methods for conducting assays with improved sensitivity using sedimentation
WO2012118982A2 (en) 2011-03-02 2012-09-07 Sandia Corporation Axial flow heat exchanger devices and methods for heat transfer using axial flow devices
EP2761269B1 (en) * 2011-09-30 2016-11-02 Hewlett Packard Development Company, L.P. Devices to detect a substance and methods of producing such a device
US9244065B1 (en) 2012-03-16 2016-01-26 Sandia Corporation Systems, devices, and methods for agglutination assays using sedimentation
JP6120518B2 (en) * 2012-10-10 2017-04-26 公益財団法人かずさDna研究所 Simple measuring instrument
CA2900708C (en) 2013-03-13 2021-06-15 Opko Diagnostics, Llc Mixing of fluids in fluidic systems
US9803238B1 (en) 2013-11-26 2017-10-31 National Technology & Engineering Solutions Of Sandia, Llc Method and apparatus for purifying nucleic acids and performing polymerase chain reaction assays using an immiscible fluid
US11318479B2 (en) 2013-12-18 2022-05-03 Berkeley Lights, Inc. Capturing specific nucleic acid materials from individual biological cells in a micro-fluidic device
US9702871B1 (en) 2014-11-18 2017-07-11 National Technology & Engineering Solutions Of Sandia, Llc System and method for detecting components of a mixture including a valving scheme for competition assays
US10279345B2 (en) 2014-12-12 2019-05-07 Opko Diagnostics, Llc Fluidic systems comprising an incubation channel, including fluidic systems formed by molding
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
AU2015406891A1 (en) * 2015-08-21 2018-03-15 Deakin University A microfluidic device and methods for manufacturing same
CN105259356B (en) * 2015-10-09 2017-09-01 张晓杰 The full-automatic ELISA detection means and its detection method of microspironema pallidum on a kind of micro-fluidic chip
CN108495712A (en) 2015-11-23 2018-09-04 伯克利之光生命科技公司 Generated in-situ microfluid isolation structure, kit and its application method
TWI758265B (en) 2015-12-08 2022-03-21 美商伯克利之光生命科技公司 In situ-generated microfluidic assay structures, related kits, and methods of use thereof
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
US10406528B1 (en) 2016-08-04 2019-09-10 National Technology & Engineering Solutions Of Sandia, Llc Non-contact temperature control system for microfluidic devices
US10786811B1 (en) 2016-10-24 2020-09-29 National Technology & Engineering Solutions Of Sandia, Llc Detection of active and latent infections with microfluidic devices and systems thereof
CN106513068B (en) * 2016-10-25 2018-10-30 清华大学 The solution and its application that micro-fluidic chip bonding for polymerizable material is modified with surface
DE102018200518B4 (en) * 2018-01-15 2023-09-14 Robert Bosch Gmbh Microfluidic device and method for its operation
WO2020018073A1 (en) 2018-07-17 2020-01-23 Hewlett-Packard Development Company, L.P. Droplet ejectors with target media
WO2019209273A1 (en) 2018-04-24 2019-10-31 Hewlett-Packard Development Company, L.P. Microfluidic devices
WO2019209375A1 (en) * 2018-04-24 2019-10-31 Hewlett-Packard Development Company, L.P. Droplet ejectors to draw fluids through microfluidic networks
WO2020018074A1 (en) 2018-07-17 2020-01-23 Hewlett-Packard Development Company, L.P. Droplet ejectors to provide fluids to droplet ejectors
CN109060793B (en) * 2018-09-08 2023-06-09 重庆科技学院 Paper-based micro-fluidic chip for detecting heavy metal ions in multiple channels
CN109806921B (en) * 2019-03-06 2021-07-23 安徽中医药高等专科学校 Preparation method of cloth chip and cloth chip

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858188A (en) * 1990-02-28 1999-01-12 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US5770029A (en) * 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
US5569364A (en) * 1992-11-05 1996-10-29 Soane Biosciences, Inc. Separation media for electrophoresis
WO1994026414A1 (en) * 1993-05-17 1994-11-24 Syntex (U.S.A.) Inc. Reaction container for specific binding assays and method for its use
US5423966A (en) * 1994-01-25 1995-06-13 Perkin-Elmer Corporation On line ion contaminant removal apparatus and method for capillary electrophoresis
WO1996042013A1 (en) * 1995-06-08 1996-12-27 Visible Genetics Inc. Microelectrophoresis chip for moving and separating nucleic acids and other charged molecules
US5872010A (en) * 1995-07-21 1999-02-16 Northeastern University Microscale fluid handling system
US5759779A (en) * 1995-08-29 1998-06-02 Dehlinger; Peter J. Polynucleotide-array assay and methods
US5672297A (en) * 1995-10-27 1997-09-30 The Dow Chemical Company Conductive composite articles based on expandable and contractible particulate matrices
AU7672796A (en) * 1995-11-08 1997-05-29 Francis H. Kirkpatrick Methods and reagents for gel electrophoresis
US5997961A (en) * 1998-03-06 1999-12-07 Battelle Memorial Institute Method of bonding functional surface materials to substrates and applications in microtechnology and antifouling
US6306590B1 (en) * 1998-06-08 2001-10-23 Caliper Technologies Corp. Microfluidic matrix localization apparatus and methods
US6391937B1 (en) * 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
US6361958B1 (en) * 1999-11-12 2002-03-26 Motorola, Inc. Biochannel assay for hybridization with biomaterial
US7005050B2 (en) * 2001-10-24 2006-02-28 The Regents Of The University Of Michigan Electrophoresis in microfabricated devices using photopolymerized polyacrylamide gels and electrode-defined sample injection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0046595A1 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109174788A (en) * 2018-08-19 2019-01-11 清华大学 Microballoon cleans chip and the microballoon cleaning device comprising it
WO2020078077A1 (en) * 2018-10-15 2020-04-23 京东方科技集团股份有限公司 Generation method and generation chip for micro sample

Also Published As

Publication number Publication date
CA2361923A1 (en) 2000-08-10
US20020153251A1 (en) 2002-10-24
JP2002536640A (en) 2002-10-29
WO2000046595A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
US20020153251A1 (en) Multichannel control in microfluidics
EP0996547B1 (en) The production of microstructures for use in assays
US8841116B2 (en) Inline-injection microdevice and microfabricated integrated DNA analysis system using same
US6274089B1 (en) Microfluidic devices, systems and methods for performing integrated reactions and separations
EP2014761B1 (en) A device for processing an analyte and a method of processing and/or detecting an analyte using said device
CA2284779C (en) Controlled fluid transport in microfabricated polymeric substrates
AU747464B2 (en) Microfluidic devices, systems and methods for performing integrated reactions and separations
JP4323743B2 (en) Polymer valve
JP4783385B2 (en) Integrated electrodynamic circuit
US20050023156A1 (en) Nanostructured material transport devices and their fabrication by application of molecular coatings to nanoscale channels
US20050034990A1 (en) System and method for electrokinetic trapping and concentration enrichment of analytes in a microfluidic channel
US20060207877A1 (en) Microfluidic device with various surface properties fabricated in multilayer body by plasma etching
US9201069B2 (en) Microfluidic devices and methods including porous polymer monoliths
EP1521634B1 (en) A method of producing a microfluidic device
AU760310B2 (en) Controlled fluid transport in microfabricated polymeric substrates
Pépin et al. Soft lithography and imprint-based techniques for microfluidics and biological analysis
Erickson Numerical simulation for microfluidic devices and the development of an electrokinetically controlled DNA hybridization chip
Leary Hydrodynamic and Mass Transport Properties of Microfluidic Geometries
Watson Towards A Microfluidic Toolbox for Proteomics: Novel Sample Pre-Processing and Separation Techniques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040430